Related Experiment Videos
[Homocysteine and diabetes].
Aleksander Januła1, Bogdan Marek, Dariusz Kajdaniuk
1Zakładu Patofizjologii Katedry Patofizjologii i Endokrynologii, Zabrzu.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 22, 2005
Summary
High homocysteine levels (hyperhomocysteinemia) are an independent risk factor for vascular disease. This review explores its specific role in diabetes, particularly in relation to vascular complications.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Metabolic Disease
Context:
- Hyperhomocysteinemia is an emerging risk factor for atherosclerosis and cardiovascular diseases.
- The specific mechanisms linking hyperhomocysteinemia to diabetes remain unclear.
- Understanding this link is crucial for managing diabetic complications.
Purpose:
- To review current knowledge on hyperhomocysteinemia's role in vascular changes.
- To investigate the unexplained connection between hyperhomocysteinemia and diabetes.
- To elucidate how hyperhomocysteinemia influences diabetic macro- and microangiopathy.
Summary:
- Elevated serum homocysteine (hyperhomocysteinemia) is an independent risk factor for arteriosclerosis and cardiovascular diseases.
- The precise role of hyperhomocysteinemia in diabetes is not fully understood.
- It likely impacts diabetes management and complications through macro- and microangiopathy development.
Impact:
- Provides a comprehensive overview of hyperhomocysteinemia in vascular disease, with a focus on diabetes.
- Highlights the need for further research into the mechanisms of hyperhomocysteinemia in diabetic patients.
- Informs clinical practice regarding the assessment and management of cardiovascular risk in diabetics with hyperhomocysteinemia.